FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072555 [Registered on: 16/08/2024] Trial Registered Prospectively
Last Modified On: 14/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Effect of Navayasa Lauha in the Management of Iron Deficiency Anaemia in School Going Children  
Scientific Title of Study   Clinical Evaluation of Navayasa Lauha in the Management of Iron Deficiency Anaemia in School Going Children – A Single Arm Interventional Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.SURENDRA SINGH GURJAR 
Designation  PG Scholar 
Affiliation  National Institute of Ayurveda 
Address  Room no: 222, KAUMARBHRITYA-BALROG,DEPARTMENT NIA JAIPUR
Jorawar singh Gate, Old amer road, Jaipur
Jaipur
RAJASTHAN
302002
India 
Phone  09414815152  
Fax    
Email  Dr.surendragurjar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Brahm Dutt Sharma 
Designation  Assistant professor  
Affiliation  National Institute of Ayurveda 
Address  Department of kaumarbhritya National Institute of Ayurveda, Jorawar singh Gate, Old amer road, Jaipur
Jorawar singh Gate, Old amer road, Jaipur
Jaipur
RAJASTHAN
302002
India 
Phone  9887859095  
Fax    
Email  dr.bdsharma@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr.SURENDRA SINGH GURJAR 
Designation  PG Scholar 
Affiliation  National Institute of Ayurveda 
Address  Room No: 222, KAUMARBHRITYA-BALROG DEPARTMENT NIA JAIPUR

Jaipur
RAJASTHAN
302002
India 
Phone  09414815152  
Fax    
Email  Dr.surendragurjar@gmail.com  
 
Source of Monetary or Material Support  
Director National Institute of Ayurveda, Jaipur, 302002 
 
Primary Sponsor  
Name  National Institute of Ayurveda 
Address  Jorawar Singh Gate, Old Amer Road, Jaipur, Rajasthan  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Surendra Singh Gurjar  National Institute of Ayurveda  OPD NO-5, BALROG OPD, National Institute of Ayurveda
Jaipur
RAJASTHAN 
09414815152

Dr.surendragurjar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee National Institute of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D508||Other iron deficiency anemias. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Navayasa Lauha, Reference: AFI PArt 2 , First English edition, 17/2, page 303, Route: Oral, Dosage Form: Lauha-Mandura, Dose: 125(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 8 Weeks, anupAna/sahapAna: Yes(details: Madhu-Ghrita), Additional Information: 6-9 years - 1/2 125mg tab (12 hourly) 10-12 years - 1 125mg tab (12 hourly)
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  1. Children aged between 06 to 12 years of either sex.
2. Children with Iron deficiency anaemia.
3. Children with Haemoglobin% less than 11.9 gm/dl and more than 7.0 gm/dl. (Mild and moderate anaemia)
 
 
ExclusionCriteria 
Details  1. Children with severe anaemia (Hb more than 7.0 gm/dl)
2. Children with major systemic illness requiring hospitalization.
3. Children with co morbidities like TB, UTI, and Bleeding disorders.
4. Children with any congenital anomalies or birth defects or genetic disorder.
5. Children with evidence of malignancy.
6. Children with concurrent serious hepatic dysfunction (defined as AST and or ALT more than 3time of the upper normal limit) or renal dysfunction (define as S. Creatinine more than 1.2mg/dl)
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Changes in Haemoglobin, RBC Count, PCV, MCV, MCH, MCHC, PBS, Serum Iron, Serum Ferritin and TIBC  2 months 
 
Secondary Outcome  
Outcome  TimePoints 
Change in quality of life in children with Iron deficiency anaemia (Pandu)   2 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Infants, preschool children, and adolescents are at greatest risk of developing iron deficiency and its resultant anaemia, which later affects their physical as well as mental development. The effect of anaemia on child development are serious: poor cognitive development, decreased future learning, and school achievement, decreased resistance to illness and disease and eventually reduced wages and quality of life. Numerous studies have shown that moderate anaemia with haemoglobin less than 10g/dl is associated with depressed mental, social, cognitive and motor development in children which may not be reversible.

Nutritional deficiency is considered to be the main culprit in Iron Deficiency Anaemia. The management programmes are exclusively aimed on providing iron and other nutrients. On the other hand, various factors that hamper the digestion and metabolism are postulated as the key etiological factors for Pandu.

Hence there is always a search for better remedies which will not cause adverse effects like gastrointestinal disturbances, metallic taste and can be well accepted by children. There are many formulations listed in different Ayurveda texts for the management of Pandu.  Among them Navayas Lauha which is explained by Acharya Charaka in Panduroga Chikitsa is the one which contains iron and other components which can correct the metabolism by which absorption and bioavailability of iron as well as other nutrients can be enhanced. Studies conducted earlier have shown that correction of metabolism is an essential part in the management of nutritional deficiency conditions.

Thus, this study is planned to clinical evaluation of Navayasa Lauha in the management of Iron Deficiency Anaemia in school going children-single arm prospective interventional trial.

 
Close